MEDIASSIST
MEDI ASSIST HEALTH SER L
Each stock's 10,000-path forecast, rendered as light.
MEDI ASSIST HEALTH SER L (MEDIASSIST) Stock Analysis & Case Study
Is MEDIASSIST a good buy? The data-driven verdict.
MEDI ASSIST HEALTH SER L (MEDIASSIST) trades at ₹369,on the numbers it tread carefully, a Downstox Snapshot Score of 33/100.
On the numbers, MEDI ASSIST HEALTH SER L (MEDIASSIST) tread carefully, a Downstox Snapshot Score of 33/100, weighing premium at 28.8× earnings, ROE of 13.9%, a 22% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
MEDIASSIST fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
Is MEDIASSIST overvalued? MEDIASSIST P/E vs its sector
MEDIASSIST's P/E of 28.8× sits above the sector peer median of 15.9×, so on earnings it screens richer than peers.
MEDIASSIST share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of MEDIASSIST history (-24%/yr drift, 39%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| MEDIASSIST 2027 | ₹161 | ₹268 | ₹441 | -26% |
| MEDIASSIST 2028 | ₹96 | ₹197 | ₹399 | -46% |
| MEDIASSIST 2029 | ₹59 | ₹142 | ₹344 | -61% |
| MEDIASSIST 2030 | ₹38 | ₹103 | ₹287 | -72% |
| MEDIASSIST 2031 | ₹24 | ₹76 | ₹233 | -79% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability MEDIASSIST goes up, or doubles?
The bull case for MEDIASSIST
- A healthy 13.9% return on equity.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹344.
The bear case & risks
- At 28.8× earnings the stock carries a premium to the market, strong growth is already in the price, so any miss tends to be punished.
- A low Piotroski F-Score of 3/9 flags weaker financial health this cycle, worth understanding why before committing.
- The probability model is cautious 12 months out, only a 22% chance of finishing above today's price.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹59.
MEDIASSIST volatility & expected range, how bumpy is the ride?
Over the last 2.0 years MEDIASSIST compounded at -24%/year with annualized volatility of 39%. That volatility implies a 1-year 80% range of ₹161–₹441, the honest backbone behind any single price target.
MEDIASSIST price forecast, the full 60-month probability fan
MEDIASSIST price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds MEDIASSIST hits common targets within the simulated horizon?
Full multi-horizon detail on the MEDIASSIST price target & forecast page.
MEDIASSIST Piotroski F-Score: 3/9, how financially strong is it?
The Piotroski F-Score grades financial strength on nine profitability, leverage and efficiency checks. MEDIASSIST scores 3/9,weak on the financial-strength checks.
MEDIASSIST MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy MEDIASSIST with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.0% | 2.9× |
| ZerodhaCHEAPEST | 33.7% | 3.0× |
| Dhan | 40.0% | 2.5× |
Compare every broker on the MEDIASSIST MTF page.
MEDIASSIST vs peers,sector comparison
About MEDI ASSIST HEALTH SER L: sector, index & market-cap context
MEDI ASSIST HEALTH SER L (MEDIASSIST) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index group, with a market capitalisation of ₹2,765 Cr. See more Nifty 500 stocks.
How the MEDIASSIST Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of MEDI ASSIST HEALTH SER L's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
MEDIASSIST analysis, FAQs
Is MEDI ASSIST HEALTH SER L (MEDIASSIST) a good buy?
On the numbers, MEDI ASSIST HEALTH SER L (MEDIASSIST) tread carefully, a Downstox Snapshot Score of 33/100, weighing premium at 28.8× earnings, ROE of 13.9%, a 22% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is MEDIASSIST overvalued or undervalued?
MEDIASSIST trades at 28.8× earnings versus a peer median of 15.9×, so it screens richer than its sector peers.
What is the MEDIASSIST share price target for 2031?
MEDIASSIST's probability-weighted 2031 median target is ₹76, with an 80% range of ₹24–₹233 (10,000-path Monte-Carlo).
What is the probability MEDIASSIST doubles in 5 years?
The modelled probability of MEDIASSIST reaching ₹729 (2×) within 5 years is 1%.
What is the bull case for MEDIASSIST?
A healthy 13.9% return on equity.
What are the risks in MEDIASSIST?
At 28.8× earnings the stock carries a premium to the market, strong growth is already in the price, so any miss tends to be punished. A low Piotroski F-Score of 3/9 flags weaker financial health this cycle, worth understanding why before committing. The probability model is cautious 12 months out, only a 22% chance of finishing above today's price.